GRAIL, Inc.

Healthcare · Diagnostics & Research · United States

Last price 143.43 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 6.41B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology...